Compare IRMD & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRMD | BXMX |
|---|---|---|
| Founded | 1992 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2014 | N/A |
| Metric | IRMD | BXMX |
|---|---|---|
| Price | $96.20 | $13.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 60.3K | ★ 124.2K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 0.83% | ★ 7.24% |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $11.99 | N/A |
| Revenue Next Year | $9.91 | N/A |
| P/E Ratio | $55.08 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $47.48 | $11.25 |
| 52 Week High | $107.90 | $15.00 |
| Indicator | IRMD | BXMX |
|---|---|---|
| Relative Strength Index (RSI) | 41.34 | 29.96 |
| Support Level | $92.51 | N/A |
| Resistance Level | $98.44 | $14.64 |
| Average True Range (ATR) | 2.89 | 0.21 |
| MACD | -0.53 | -0.07 |
| Stochastic Oscillator | 25.83 | 0.65 |
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.